Human laminin-111 and laminin-211 protein therapy prevents muscle disease progression in an immunodeficient mouse model of LAMA2-CMD

Pamela Barraza-Flores, Hailey J. Hermann, Christina R. Bates, Tyler G. Allen, Timothy T. Grunert, Dean J. Burkin

Open source

DOI
10.1186/s13395-020-00235-4
Published
2020-06-04
Container
Skeletal Muscle
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s13395-020-00235-4,
  title = {Human laminin-111 and laminin-211 protein therapy prevents muscle disease progression in an immunodeficient mouse model of LAMA2-CMD},
  author = {Pamela Barraza-Flores and Hailey J. Hermann and Christina R. Bates and Tyler G. Allen and Timothy T. Grunert and Dean J. Burkin},
  year = {2020},
  journal = {Skeletal Muscle},
  doi = {10.1186/s13395-020-00235-4},
  url = {https://doi.org/10.1186/s13395-020-00235-4}
}

RIS

TY  - JOUR
TI  - Human laminin-111 and laminin-211 protein therapy prevents muscle disease progression in an immunodeficient mouse model of LAMA2-CMD
AU  - Pamela Barraza-Flores
AU  - Hailey J. Hermann
AU  - Christina R. Bates
AU  - Tyler G. Allen
AU  - Timothy T. Grunert
AU  - Dean J. Burkin
PY  - 2020
JO  - Skeletal Muscle
DO  - 10.1186/s13395-020-00235-4
UR  - https://doi.org/10.1186/s13395-020-00235-4
ER  - 

APA

Barraza-Flores, P., Hermann, H. J., Bates, C. R., Allen, T. G., Grunert, T. T., & Burkin, D. J. (2020). Human laminin-111 and laminin-211 protein therapy prevents muscle disease progression in an immunodeficient mouse model of LAMA2-CMD. Skeletal Muscle. https://doi.org/10.1186/s13395-020-00235-4

Source records